Literature DB >> 2422944

Expression of HLA class I antigens on hepatocytes in liver disease.

T Fukusato, M A Gerber, S N Thung, S Ferrone, F Schaffner.   

Abstract

Recent studies have demonstrated aberrant expression and topographical heterogeneity of HLA Class I and Class II antigens in tissues of patients with certain immunologic or neoplastic diseases. Current information about the expression of HLA antigens by normal and diseased hepatocytes is controversial. We analyzed the HLA antigenic profile of 4 normal fetal livers, 5 normal adult livers, 7 cases of chronic hepatitis B virus (HBV) infection, 14 cases of cirrhosis of various etiologies, 11 hepatic neoplasms, and 5 continuous cell lines derived from hepatic tumors. The specimens were tested by the indirect fluorescent antibody method with a panel of monoclonal antibodies to distinct monomorphic determinants of HLA Class I and Class II antigens and to beta 2-microglobulin. HLA Cells I antigens were not detected on normal fetal and adult hepatocytes, but were displayed on the plasma membrane of hepatocytes in the majority of all hepatic diseases tested and of the 5 hepatic tumor cell lines. There was a significant correlation between the expression of HLA Class I antigens on hepatocytes and the intensity of intralobular inflammation. Double immunofluorescent staining of livers infected with hepatitis B virus demonstrated simultaneous expression of HLA Class I antigens and HBsAg or HBcAg only in a small percentage of hepatocytes, suggesting lack of a specific association between HLA Class I and these viral antigens. HLA Class II antigens were not detected on hepatocytes from any of the liver diseases tested but were expressed by one of the 5 liver carcinoma cell lines analyzed. These findings confirm that HLA Class I antigens are not detectable within the limits of several immunohistochemical methods on normal hepatocytes and suggest that injury by a variety of factors directly or indirectly leads to induction of these antigens on the plasma membrane of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422944      PMCID: PMC1888314     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

Review 1.  Human DR (Ia-like) antigens: biological and molecular profile.

Authors:  S Ferrone; J P Allison; M A Pellegrino
Journal:  Contemp Top Mol Immunol       Date:  1978

2.  Qualitative and quantitative evaluation of indirect immunofluorescent H-2 stain on tissue sections.

Authors:  D A Saunders; T F Beals; J S Schultz
Journal:  Tissue Antigens       Date:  1979-08

3.  Diversity of expression of H-2 antigens on mouse liver cells demonstrated by immunoferritin labeling.

Authors:  E L Parr
Journal:  Transplantation       Date:  1979-01       Impact factor: 4.939

Review 4.  The immunoglobulin-like structure of human histocompatibility antigens.

Authors:  J L Strominger; P Cresswell; H Grey; R E Humphreys; D Mann; P Parham; R Robb; A R Sanderson; T A Springer; C Terhorst; M J Turner
Journal:  Transplant Rev       Date:  1974

5.  Purification of immunologically functional subsets of human Ia-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent.

Authors:  V Quaranta; L E Walker; M A Pellegrino; S Ferrone
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

6.  Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.

Authors:  P Parham; C J Barnstable; W F Bodmer
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

7.  Distribution and quantitation of HLA-ABC and DR (Ia) antigens on human kidney and other tissues.

Authors:  K A Williams; D N Hart; J W Fabre; P J Morris
Journal:  Transplantation       Date:  1980-04       Impact factor: 4.939

8.  The detailed distribution of HLA-A, B, C antigens in normal human organs.

Authors:  A S Daar; S V Fuggle; J W Fabre; A Ting; P J Morris
Journal:  Transplantation       Date:  1984-09       Impact factor: 4.939

9.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

10.  Distribution of five antigens in hepatocellular carcinoma.

Authors:  S N Thung; M A Gerber; E Sarno; H Popper
Journal:  Lab Invest       Date:  1979-08       Impact factor: 5.662

View more
  25 in total

1.  Induction of HLA-DR antigen expression in human endometrial epithelial cells in vitro by recombinant gamma-interferon.

Authors:  S S Tabibzadeh; M A Gerber; P G Satyaswaroop
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

2.  Distribution of the MHC antigens after liver transplantation: relationship with biochemical and histological parameters.

Authors:  P Rouger; J Gugenheim; P Gane; M Capron-Landereau; F Michel; M Reynes; J Bismuth
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

3.  Soluble HLA class I antigens in sera of patients with chronic hepatitis.

Authors:  K Sakaguchi; N Koide; T Takenami; H Matsushima; H Takabatake; S Ferrone; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1992-04

4.  Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease.

Authors:  K Koretz; F Momburg; H F Otto; P Möller
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

5.  HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease.

Authors:  G Ballardini; F B Bianchi; R Mirakian; M Fallani; E Pisi; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

6.  Immunohistochemical investigation of hepatitis B virus associated antigens, HLA antigens and lymphocyte subsets in type B chronic hepatitis.

Authors:  K Aoyama; T Kojima; K Inoue; H Sasaki
Journal:  Gastroenterol Jpn       Date:  1990-02

7.  Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment.

Authors:  R Wejstål; G Norkrans; O Weiland; R Schvarcz; D Fuchs; H Wachter; A Fryden; H Glaumann
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

8.  Altered growth of a human neuroendocrine carcinoma line after transfection of a major histocompatibility complex class I gene.

Authors:  M E Sunday; K J Isselbacher; S Gattoni-Celli; C G Willett
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

9.  Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology.

Authors:  J Y Lau; G L Bird; N V Naoumov; R Williams
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

10.  Liver disease in rhesus monkeys infected with simian immunodeficiency virus.

Authors:  M A Gerber; M L Chen; F S Hu; G B Baskin; L Petrovich
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.